all stories

Eli Lilly and Company (NYSE:LLY) Trading 4.9% Higher After Better-Than-Expected Earnings

Steadysecond windCoverage went quiet for 8 days, then returned with 9 more reports - 6 voices in all.
original reportingcopies
Wed, 5 August 2026peak 4 reports on Fri, 4 September 2026Sat, 5 September 2026

What it is about

Eli LillyCompany Dividend AnnouncementMaryland Capital Advisors IncCompany StockCompany DailyE Fund Management Hong Kong CoFund Management Hong Kong CoCompany NewsEngland Capital Financial AdvisorsGoldman Sachs GroupOsbon Capital ManagementAmericaMaryland, United StatesHong KongIndiana, United StatesEli Lilly IncretinCompany Announces DividendJpmorgan Chase CoCompany Price PerformanceBarclays

Who published it, and when

original reportcopyfirst to report
themarketsdaily.com1 original report1 original report1 original report1 original report
yahoo.com1 original report1 copy echoing insidermonkey.com1 original report
insidermonkey.com1 original report
fool.com1 original report1 original report
aol.com1 original report
dailypolitical.com4 original reports
5 Aug, 21:00over 31 days5 Sept, 18:32

1 report left out of the cascade - too little in common with the story to place

How it spread - 15 original reports, 1 reprint

  1. Wed, 5 August 2026

    1 report
    • themarketsdaily.com21:00first to report

      Shares of Eli Lilly and Company (NYSE:LLY – Get Free Report) were up 4.9% on Wednesday following a stronger than expected earnings report. The stock traded as high as $1,216.94 and last traded at $1,170.2960. Approximately 6,403,230 shares were traded during trading, an increase of 104% from the average daily volume of 3,135,686 shares. The […]

  2. Sat, 8 August 2026

    2 reports
    • themarketsdaily.com13:14

      Eli Lilly and Company (NYSE:LLY – Free Report) had its target price raised by Truist Financial from $1,370.00 to $1,376.00 in a research report report published on Friday morning,Benzinga reports. Truist Financial currently has a buy rating on the stock. LLY has been the topic of a number of other reports. JPMorgan Chase & Co. […]

    • yahoo.com18:33

      Eli Lilly (LLY) posted a second-quarter result strong enough to shift the debate around its stock. For months, the debate centered on one worry: a slow start for its new obesity pill. That worry did not disappear in the second quarter, but it stopped driving the conversation. Bank of America came ...

  3. Sun, 9 August 2026

    2 reports
    • insidermonkey.com08:51

      Eli Lilly (NYSE:LLY) delivered a quarter that forced Wall Street to catch up to its own numbers.

    • themarketsdaily.com17:04

      Eli Lilly and Company, Johnson & Johnson, McKesson, AbbVie, and Pfizer are the five Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool. Pharmaceutical stocks are shares of publicly traded companies that discover, develop, manufacture, or market medicines and other drug products. For stock market investors, these stocks represent ownership in the pharmaceutical […]

  4. Sat, 15 August 2026

    1 report
  5. Mon, 24 August 2026

    1 report
  6. Sun, 30 August 2026

    1 report
  7. Tue, 1 September 2026

    1 report
  8. Wed, 2 September 2026

    1 report
    • themarketsdaily.com08:59

      Glenview Trust Co bought a new stake in Eli Lilly and Company (NYSE:LLY – Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 188,484 shares of the company’s stock, valued at approximately $226,073,000. Eli Lilly and Company comprises approximately […]

  9. Fri, 4 September 2026

    4 reports
    • dailypolitical.com05:39

      UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in Eli Lilly and Company (NYSE:LLY – Free Report) by 1.9% during the second quarter, HoldingsChannel.com reports. The institutional investor owned 7,209,385 shares of the company’s stock after buying an additional 137,364 shares during the period. Eli Lilly and Company […]

    • dailypolitical.com05:39

      Rational Advisors Inc. grew its holdings in Eli Lilly and Company (NYSE:LLY – Free Report) by 106.5% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,236 shares of the company’s stock after purchasing an additional 1,669 shares during the period. Rational […]

    • dailypolitical.com05:39

      Manchester Financial Inc. decreased its holdings in Eli Lilly and Company (NYSE:LLY – Free Report) by 75.9% in the second quarter, Holdings Channel.com reports. The institutional investor owned 467 shares of the company’s stock after selling 1,468 shares during the period. Manchester Financial Inc.’s holdings in Eli Lilly and Company were worth $560,000 as of […]

    • dailypolitical.com05:39

      Toth Financial Advisory Corp grew its holdings in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 282.0% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,207 shares of the company’s stock after purchasing an additional 891 shares […]

  10. Sat, 5 September 2026

    1 report

One email a week

The stories everytrace watched stay alive - how many independent outlets carried each one, and how long it lasted. No daily digest, no breaking-news alerts.